A randomized, double-blind, placebo-controlled trial conducted at 96 sites in 13 countries in Asia, Europe, and North and South America, the Effect of Semaglutide 2.4 mg Once Weekly on Function and Symptoms in Subjects with Obesity-related Heart Failure with Preserved Ejection Fraction (STEP-HFpEF) trial was designed to explore whether semaglutide 2.4 mg could improve symptoms and physical function among patients with HFpEF and obesity
Over-the-counter remedies may provide symptomatic relief
The quality of the weight loss
This includes adopting a healthy diet and engaging in regular physical activity
Si tu dolor abdominal es fuerte o tienes seales de deshidratacin, como mareos o dificultad para orinar, llama al consultorio de tu mdico de inmediato
Conclusion Feeling cold while taking Wegovy is a manageable side effect that many people encounter on their path to better health